Fundai

Tamin Pharmaceutical Investment Company (TIPIKO) cash flow statement

Operating, investing and financing cash flows, and the closing balance

Ticker
TIPIKO
Industry
Pharmaceuticals
Market
Tehran Stock Exchange

Latest periods

Latest 3-month periods, in million rials
ItemTo 1404/05/31To 1403/05/31To 1402/05/31To 1401/05/31To 1400/05/31To 1399/05/31
Cash generated from operations1,004,3615,206,6712,552,4051,250,0411,197,771949,430
Net cash inflow (outflow) from operating activities1,004,3615,206,6712,552,4051,250,0411,197,771949,430
Cash payments for purchase of property, plant and equipment-3,340-40,463-726-3,839-189-3,102
Net cash inflow (outflow) before financing activities1,001,021327,071-862,468-2,202,171-87,131394,655
Cash payments for purchase of treasury shares-100,00000000
Cash payments for dividends-1,590,150-4,839,137-3,414,147-3,448,373-1,284,713-551,090
Net cash inflow (outflow) from financing activities-1,690,15000000
Net increase (decrease) in cash-689,129327,071-862,468-2,202,171-87,131394,655
Cash balance at beginning of year1,647,7041,080,4711,752,2533,229,469761,356342,647
Cash balance at end of year958,5751,407,588889,7821,027,298674,533737,314

Reporting periods

61 periods are on file for this report, from the period ending 1385/02/31 to the period ending 1405/05/31.